Displaying One Session

Channel 1 Tue, 02.03.2021 16:00 - 17:00
Date
Tue, 02.03.2021
Time
16:00 - 17:00
Location
Channel 1
Chairs
  • Giuseppe Curigliano (Milan, Italy)
Daiichi Sankyo - Innovative Antibody Engineering: Novel technologies and preclinical and clinical outcomes Industry satellite

Introduction (ID 347)

Lecture Time
16:00 - 16:10
Speakers
  • Giuseppe Curigliano (Milan, Italy)
Location
Channel 1, Virtual, Lugano, Switzerland
Date
Tue, 02.03.2021
Time
16:00 - 17:00
Authors
  • Giuseppe Curigliano (Milan, Italy)
Daiichi Sankyo - Innovative Antibody Engineering: Novel technologies and preclinical and clinical outcomes Industry satellite

Antibody engineering: Novel technologies, antibody drug conjugates and mechanisms of action (ID 348)

Lecture Time
16:10 - 16:30
Speakers
  • Matthias Peipp (Kiel, Germany)
Location
Channel 1, Virtual, Lugano, Switzerland
Date
Tue, 02.03.2021
Time
16:00 - 17:00
Authors
  • Matthias Peipp (Kiel, Germany)
Daiichi Sankyo - Innovative Antibody Engineering: Novel technologies and preclinical and clinical outcomes Industry satellite

Emerging preclinical and clinical data with novel antibody drug conjugates in various tumour types (ID 349)

Lecture Time
16:30 - 16:50
Speakers
  • Giuseppe Curigliano (Milan, Italy)
Location
Channel 1, Virtual, Lugano, Switzerland
Date
Tue, 02.03.2021
Time
16:00 - 17:00
Authors
  • Giuseppe Curigliano (Milan, Italy)
Daiichi Sankyo - Innovative Antibody Engineering: Novel technologies and preclinical and clinical outcomes Industry satellite

Q&A (ID 350)

Lecture Time
16:50 - 17:00
Speakers
  • Giuseppe Curigliano (Milan, Italy)
Location
Channel 1, Virtual, Lugano, Switzerland
Date
Tue, 02.03.2021
Time
16:00 - 17:00
Authors
  • Giuseppe Curigliano (Milan, Italy)
  • Matthias Peipp (Kiel, Germany)